119 related articles for article (PubMed ID: 15254330)
1. A minimally invasive method to evaluate 131I kinetics in blood.
Traino AC; Di Martino F; Boni G; Mariani G; Lazzeri M
Radiat Prot Dosimetry; 2004; 109(3):249-52. PubMed ID: 15254330
[TBL] [Abstract][Full Text] [Related]
2. Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe?
de Carvalho JW; Sapienza M; Ono C; Watanabe T; Guimarães MI; Gutterres R; Marechal MH; Buchpiguel C
Nucl Med Commun; 2009 Jul; 30(7):533-41. PubMed ID: 19436231
[TBL] [Abstract][Full Text] [Related]
3. The effects of dialysis on 131I kinetics and dosimetry in thyroid cancer patients--a pharmacokinetic model.
Pahlka RB; Sonnad JR
Health Phys; 2006 Sep; 91(3):227-37. PubMed ID: 16891898
[TBL] [Abstract][Full Text] [Related]
4. Iodine-131 in breast milk following therapy for thyroid carcinoma.
Robinson PS; Barker P; Campbell A; Henson P; Surveyor I; Young PR
J Nucl Med; 1994 Nov; 35(11):1797-801. PubMed ID: 7965159
[TBL] [Abstract][Full Text] [Related]
5. Radiation dose to the upper spine from therapeutic administrations of iodine-131-sodium iodide.
Stabin MG
J Nucl Med; 1993 Apr; 34(4):695-6. PubMed ID: 8455090
[TBL] [Abstract][Full Text] [Related]
6. Radioactive iodine in thyroid medicine--how it started in Sweden and some of today's challenges.
Mattsson S; Johansson L; Jönsson H; Nosslin B
Acta Oncol; 2006; 45(8):1031-6. PubMed ID: 17118834
[TBL] [Abstract][Full Text] [Related]
7. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
Hänscheid H; Lassmann M; Luster M; Thomas SR; Pacini F; Ceccarelli C; Ladenson PW; Wahl RL; Schlumberger M; Ricard M; Driedger A; Kloos RT; Sherman SI; Haugen BR; Carriere V; Corone C; Reiners C
J Nucl Med; 2006 Apr; 47(4):648-54. PubMed ID: 16595499
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison.
Wessels BW; Bolch WE; Bouchet LG; Breitz HB; Denardo GL; Meredith RF; Stabin MG; Sgouros G;
J Nucl Med; 2004 Oct; 45(10):1725-33. PubMed ID: 15471841
[TBL] [Abstract][Full Text] [Related]
9. Radioactivity of blood samples taken from thyroidectomized thyroid carcinoma patients after therapy with (131)I.
Larkin A; Millan E; Noz M; Wagner S; Friedman K; Blum M
Thyroid; 2011 Sep; 21(9):1009-12. PubMed ID: 21834682
[TBL] [Abstract][Full Text] [Related]
10. Optimized 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer.
Jentzen W; Freudenberg L; Eising EG; Sonnenschein W; Knust J; Bockisch A
J Nucl Med; 2008 Jun; 49(6):1017-23. PubMed ID: 18483099
[TBL] [Abstract][Full Text] [Related]
11. [Environmental radiation exposure of a thyroid cancer patient resulting from adjuvant iodine radiotherapy].
Chaś J; Kowalczyk A; Siekierzyński M; Dziuk E; Janiak MK
Wiad Lek; 2001; 54 Suppl 1():312-20. PubMed ID: 12182042
[TBL] [Abstract][Full Text] [Related]
12. Hospital discharge of patients with thyroid carcinoma treated with 131I.
Venencia CD; Germanier AG; Bustos SR; Giovannini AA; Wyse EP
J Nucl Med; 2002 Jan; 43(1):61-5. PubMed ID: 11801704
[TBL] [Abstract][Full Text] [Related]
13. [Problems with radiation protection for adjuvant radiotherapy of thyroid cancer].
Siekierzyński M
Wiad Lek; 2001; 54 Suppl 1():307-11. PubMed ID: 12182040
[TBL] [Abstract][Full Text] [Related]
14. Comparison of different dosimetric methods for red marrow absorbed dose calculation in thyroid cancer therapy.
Willegaignon J; Sapienza MT; Buchpiguel CA
Radiat Prot Dosimetry; 2012 Apr; 149(2):138-46. PubMed ID: 21586539
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic administration of 131I for differentiated thyroid cancer: radiation dose to ovaries and outcome of pregnancies.
Garsi JP; Schlumberger M; Rubino C; Ricard M; Labbé M; Ceccarelli C; Schvartz C; Henri-Amar M; Bardet S; de Vathaire F
J Nucl Med; 2008 May; 49(5):845-52. PubMed ID: 18413399
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the reticulocyte micronucleus assay in patients treated with radioiodine for thyroid cancer.
Grawé J; Biko J; Lorenz R; Reiners C; Stopper H; Vershenya S; Vukicevic V; Hempel K
Mutat Res; 2005 May; 583(1):12-25. PubMed ID: 15866462
[TBL] [Abstract][Full Text] [Related]
17. Iodine-131 pharmacokinetics in patients on hemodialysis for end stage renal disease: clinical implications.
Courbon F; Caselles O; Zerdoud S; Duthil P; Regis H; Berry I; Caron P
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):363-70. PubMed ID: 17043635
[TBL] [Abstract][Full Text] [Related]
18. Glycophorin A as a biological dosimeter for radiation dose to the bone marrow from iodine-131.
Jensen RH; Reynolds JC; Robbins J; Bigbee WL; Grant SG; Langlois RG; Pineda JD; Lee T; Barker WC
Radiat Res; 1997 Jun; 147(6):747-52. PubMed ID: 9189175
[TBL] [Abstract][Full Text] [Related]
19. Radiation safety protocol for high dose 131I therapy of thyroid carcinoma in patients on hemodialysis for chronic renal failure.
Modarresifar H; Almodovar S; Bass WB; Ojha B
Health Phys; 2007 Feb; 92(2 Suppl):S45-9. PubMed ID: 17228187
[TBL] [Abstract][Full Text] [Related]
20. [Study and implementation of a computerized program for personalized prescriptions for patients treated with radioiodine to be discharged].
Puccini S; Traino AC; Ferdeghini M; Bodei L; Lazzeri M
Radiol Med; 1999 Apr; 97(4):279-85. PubMed ID: 10414262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
